Cargando…

Hearing loss in children with Fabry disease

BACKGROUND: Hearing loss (HL) is a well-known feature of Fabry disease (FD). Its presence and characteristics have mainly been studied in adult patients, while only limited data are available on the presence and degree of HL in children with FD. This prompted us to study hearing sensitivity in pedia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suntjens, E., Dreschler, W. A., Hess-Erga, J., Skrunes, R., Wijburg, F. A., Linthorst, G. E., Tøndel, C., Biegstraaten, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579138/ https://www.ncbi.nlm.nih.gov/pubmed/28567540 http://dx.doi.org/10.1007/s10545-017-0051-5

Ejemplares similares

Pain management strategies for neuropathic pain in Fabry disease - a systematic review
por: Schuller, Y., et al.
Publicado: (2016)

Erratum to: Pain management strategies for neuropathic pain in Fabry disease - a systematic review
por: Schuller, Y., et al.
Publicado: (2016)

Poikilothermia in a 38-year-old Fabry patient
por: Biegstraaten, Marieke, et al.
Publicado: (2010)

Prevalence of symptoms in female Fabry disease patients: a case-control survey
por: Bouwman, Machtelt G., et al.
Publicado: (2012)

Autonomic neuropathy in Fabry disease: a prospective study using the Autonomic Symptom Profile and cardiovascular autonomic function tests
por: Biegstraaten, Marieke, et al.
Publicado: (2010)

Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
por: Biegstraaten, Marieke, et al.
Publicado: (2015)

Characterization of vertigo and hearing loss in patients with Fabry disease
por: Köping, Maria, et al.
Publicado: (2018)

Quality of life in patients with Fabry disease: a systematic review of the literature
por: Arends, Maarten, et al.
Publicado: (2015)

What Is the Role of Sensorineural Hearing Loss in Fabry Disease Screening?
por: Köroğlu, Ekin Yiğit, et al.
Publicado: (2023)

Association of Fabry Disease with Hearing Loss, Tinnitus, and Sudden Hearing Loss: A Nationwide Population-Based Study
por: Cheng, Yen-Fu, et al.
Publicado: (2022)

Accuracy of an internet-based speech-in-noise hearing screening test for high-frequency hearing loss: incorporating automatic conditional rescreening
por: Sheikh Rashid, Marya, et al.
Publicado: (2018)

Cost-effectiveness of enzyme replacement therapy for Fabry disease
por: Rombach, Saskia M, et al.
Publicado: (2013)

Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease
por: Köping, Maria, et al.
Publicado: (2017)

Fabry disease presenting with sudden hearing loss and otosclerosis: a case report
por: Felisati, Giovanni, et al.
Publicado: (2012)

A retrospective analysis of noise-induced hearing loss in the Dutch construction industry
por: Leensen, M. C. J., et al.
Publicado: (2011)

Significant hearing loss in Fabry disease: Study of the Danish nationwide cohort prior to treatment
por: Yazdanfard, Puriya Daniel, et al.
Publicado: (2019)

Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain
por: Rombach, Saskia M, et al.
Publicado: (2013)

Long-Term Effect of Antibodies against Infused Alpha-Galactosidase A in Fabry Disease on Plasma and Urinary (lyso)Gb3 Reduction and Treatment Outcome
por: Rombach, Saskia M., et al.
Publicado: (2012)

Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort study
por: Arends, Maarten, et al.
Publicado: (2017)

Otological aspects of Fabry disease in patients with normal hearing
por: Wang, Fei, et al.
Publicado: (2019)

Letter concerning “Enzyme replacement therapy in a patient with Fabry disease and the development of IgE antibodies against agalsidase beta but not agalsidase alpha”, by Tanaka et al.
por: Linthorst, Gabor E., et al.
Publicado: (2010)

Factors associated with change in the need for recovery and subjective listening effort in employees with hearing loss receiving aural rehabilitation
por: van der Hoek-Snieders, Hanneke E. M., et al.
Publicado: (2022)

Hearing loss in fabry disease: A 16 year follow-up study of the Danish nationwide cohort
por: Yazdanfard, Puriya Daniel Würtz, et al.
Publicado: (2022)

Factors influencing the need for recovery in employees with hearing loss: a cross-sectional study of health administrative data
por: van der Hoek-Snieders, Hanneke E. M., et al.
Publicado: (2020)

Classification of Hearing Aids Into Feature Profiles Using Hierarchical Latent Class Analysis Applied to a Large Dataset of Hearing Aids
por: Lansbergen, Simon, et al.
Publicado: (2020)

Exploring Factors That Contribute to the Success of Rehabilitation With Hearing Aids
por: Lansbergen, Simon E., et al.
Publicado: (2023)

Characterization of Early Disease Status in Treatment-Naive Male Paediatric Patients with Fabry Disease Enrolled in a Randomized Clinical Trial
por: Wijburg, Frits A., et al.
Publicado: (2015)

Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry Nephropathy
por: Fall, Brent, et al.
Publicado: (2016)

Mosaicism of Podocyte Involvement Is Related to Podocyte Injury in Females with Fabry Disease
por: Mauer, Michael, et al.
Publicado: (2014)

Relations Between the Intelligibility of Speech in Noise and Psychophysical Measures of Hearing Measured in Four Languages Using the Auditory Profile Test Battery
por: Van Esch, T. E. M., et al.
Publicado: (2015)

The etiological evaluation of sensorineural hearing loss in children
por: van Beeck Calkoen, E. A., et al.
Publicado: (2019)

Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy
por: Schiffmann, Raphael, et al.
Publicado: (2009)

Trajectory of hearing loss in children with unilateral hearing loss
por: Fitzpatrick, Elizabeth M., et al.
Publicado: (2023)

Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors
por: Arends, Maarten, et al.
Publicado: (2017)

Preferred Strength of Noise Reduction for Normally Hearing and Hearing-Impaired Listeners
por: Houben, Rolph, et al.
Publicado: (2023)

Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study
por: Arends, Maarten, et al.
Publicado: (2018)

One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease
por: Najafian, Behzad, et al.
Publicado: (2016)

A Profiling System for the Assessment of Individual Needs for Rehabilitation With Hearing Aids
por: Dreschler, Wouter A., et al.
Publicado: (2016)

Treatment of Fabry Disease: Outcome of a Comparative Trial with Agalsidase Alfa or Beta at a Dose of 0.2 mg/kg
por: Vedder, Anouk C., et al.
Publicado: (2007)

Music for children with hearing loss : a resource for parents and teachers /
por: Schraer-Joiner, Lyn E.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o8mtojghub6iijeerff79ko099